Field notes from the Thai export floor.
Briefings on TH-GACP cultivation, regulated medical-cannabis export, and the changing landscape of cross-border supply.
26 July 2026 · 4 MIN READThai farm to export: TH-GACP, DTAM licensing and the six categories in 2026
How a licensed Thai farm reaches export — TH-GACP certification, DTAM authorisation under Ministerial Regulation No. 2 B.E. 2569, and the six export-eligible categories.
FarmTH-GACPDTAMLicensing
23 July 2026 · 4 MIN READThailand BOI incentives for medical cannabis: the lawful entry route in 2026
How Thailand's Board of Investment promotion gives a foreign investor a lawful ownership and tax route into the medical-cannabis value chain, and where a broker fits.
InvestorBOIIncentivesMarket entry
20 July 2026 · 4 MIN READFrance medical cannabis import pathway: sourcing under the ANSM regime in 2026
How licensed medical cannabis reaches France in 2026 under the ANSM framework as the country shifts from experiment to generalised regime — and how Thai supply routes in.
FranceANSMImportBuyer
17 July 2026 · 4 MIN READExport-ready in 2026: how a licensed Thai farm gets there with a broker
How a licensed Thai cannabis farm becomes export-ready: TH-GACP, an ISO/IEC 17025 QA pack, DTAM's six export categories, phytosanitary and origin papers — carried by a broker.
FarmCultivationTH-GACPDTAM
14 July 2026 · 4 MIN READThailand Cannabis Investors: Lawful JV & BOI vs Illegal Nominee (2026)
Lawful routes for international investors into Thailand's medical-cannabis supply chain — JV, BOI and OEM — and why nominee shareholding is a crime under FBA §36.
InvestorJVBOIForeign ownership
11 July 2026 · 4 MIN READSwitzerland medical cannabis import pathway: the Swissmedic framework in 2026
How licensed medical cannabis enters Switzerland in 2026 — the Swissmedic narcotics and establishment framework, what a Swiss importer needs, and how Thai-origin supply routes in.
SwitzerlandImportSwissmedicBuyer
26 May 2026 · 4 MIN READAsia-Pacific medical cannabis to EU and AU: the 2026 precedents that matter
Three 2026 datapoints validate the Asia-Pacific → EU / Asia-Pacific → Australia regulated-market pathway for internationally cultivated medical cannabis: NZ → Germany (RUA Bioscience), Colombia → Australia (Avicanna CBG, March 2026), and Thailand → Italy (CannaBless 700 kg, June 2026).
Market IntelligenceComplianceEUAustralia
26 May 2026 · 4 MIN READTGA-pathway international supply: how Australian importers source Thai-origin medical cannabis
B2B importer-side companion to the TGA pathway brief. Two-licence structure (TGA + ODC), cultivator-side documentation expectations, Avicanna's March 2026 Colombia → Australia CBG precedent, and how the Thai documentation stack maps cleanly onto Australian import requirements.
AustraliaTGAComplianceInternational Supply
26 May 2026 · 4 MIN READPhu Phan Squirrel Tail: monograph of a tropical sativa cultivar
Phu Phan Squirrel Tail is a high-myrcene tropical sativa cultivar grown by the licensed TH-GACP farms in CannaBless's brokered network. The terpene profile, the tropical-latitude growing conditions, and why this cultivar is non-replicable from Canadian-latitude cultivation.
CultivarStrainTerpenesThailand
26 May 2026 · 4 MIN READUK medical cannabis import: pathway, regulator framework, and importer landscape 2026
How licensed medical cannabis enters the United Kingdom in 2026 — the Home Office Drugs Licensing & Compliance Unit, the MHRA Specials Licence framework, and the toll-processor model that internationally cultivated flower most commonly routes through.
UKMHRAHome OfficeCompliance
24 May 2026 · 5 MIN READDTAM Ministerial Regulation No. 2 B.E. 2569: what changed for Thai medical cannabis export in 2026
Thailand's new ministerial regulation (effective 1 May 2026) narrows cannabis-flower export to six licensed categories under DTAM. What AU and EU importers should verify in their Thai supplier's licence stack.
ComplianceRegulationDTAMThailand
06 May 2026 · 6 MIN READGermany's BfArM pathway for medical cannabis
How medical cannabis is imported into Germany under BfArM authorisation. CanG reform, Apothekenpflicht, EU-GMP equivalence — what importers verify.
GermanyEUBfArMCompliance
06 May 2026 · 6 MIN READDrying, curing, and packaging: post-harvest decisions
How post-harvest decisions — drying rate, cure duration, environmental controls, packaging — affect cannabinoid stability and patient dosing.
Post-harvestDryingCuringPackaging
06 May 2026 · 5 MIN READCold-chain integrity for medical cannabis
How cold-chain logistics affect THC, CBD, and terpene stability between harvest and pharmacy. Target 15-18°C, 58-62% RH, light-tight, time-bounded.
LogisticsQualityCold chainCannabinoid stability
06 May 2026 · 6 MIN READCultivar genetics, terpenes, and patient outcomes
How cannabis cultivar choice — genetics, cannabinoid ratios, terpene profiles — affects therapeutic effect and patient outcomes.
GeneticsTerpenesPatient outcomesCultivar selection
06 May 2026 · 6 MIN READMedical-grade vs craft cannabis: a sourcing audit
Four verifiable axes that separate medical-grade from craft: cultivation discipline, GMP-equivalent processing, batch consistency, documentation.
QualityMedical gradeSourcingPatient safety
06 May 2026 · 6 MIN READReading a medical-cannabis CoA: a clinician's checklist
How to read a medical-cannabis Certificate of Analysis line by line. Cannabinoids, terpenes, microbial limits, residual solvents, contaminants.
QualityCoALab testingCompliance
06 May 2026 · 5 MIN READAustralia's TGA pathway for imported medical cannabis
How imported medical cannabis reaches AU patients via SAS Category B + Authorised Prescriber. What licensed importers verify before sourcing.
AustraliaTGACompliancePatient access
06 May 2026 · 3 MIN READTH-GACP explained: a sourcing checklist for AU importers
TH-GACP is Thailand's Good Agricultural and Collection Practices standard for medicinal plants. What it covers + what to verify before sourcing.
TH-GACPComplianceAustraliaCultivation